These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9241133

  • 1. Preventing glucocorticoid-induced osteoporosis.
    Reid IR.
    N Engl J Med; 1997 Aug 07; 337(6):420-1. PubMed ID: 9241133
    [No Abstract] [Full Text] [Related]

  • 2. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
    Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA.
    N Engl J Med; 1997 Aug 07; 337(6):382-7. PubMed ID: 9241127
    [Abstract] [Full Text] [Related]

  • 3. Etidronate and glucocorticoid induced osteoporosis.
    Ortego-Centeno N, Muñoz-Torres M, Callejas-Rubio JL, Riera-Montes M.
    J Rheumatol; 2005 Jan 07; 32(1):199-200. PubMed ID: 15630758
    [No Abstract] [Full Text] [Related]

  • 4. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M, Gradowska L, Marcinowska-Suchowierska E, Durlik M, Gaciong Z, Lao M.
    Transplant Proc; 1996 Dec 07; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract] [Full Text] [Related]

  • 5. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
    Adachi JD, Roux C, Pitt PI, Cooper C, Moniz C, Dequeker J, Ioannidis G, Cawley MI, Jenkins EA, Walker-Bone KE, Pack S, Stephenson GF, Laan RF, Brown J, Geusens P.
    J Rheumatol; 2000 Oct 07; 27(10):2424-31. PubMed ID: 11036840
    [Abstract] [Full Text] [Related]

  • 6. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S, Ohosone Y, Suwa A, Yasuoka H, Nojima T, Fujii T, Kuwana M, Nakamura K, Mimori T, Hirakata M.
    J Rheumatol; 2003 Dec 07; 30(12):2673-9. PubMed ID: 14719212
    [Abstract] [Full Text] [Related]

  • 7. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
    Buckley LM, Hillner BE.
    J Rheumatol; 2003 Jan 07; 30(1):132-8. PubMed ID: 12508402
    [Abstract] [Full Text] [Related]

  • 8. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
    Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG.
    N Engl J Med; 1998 Jul 30; 339(5):292-9. PubMed ID: 9682041
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN.
    Minerva Med; 2008 Feb 30; 99(1):23-43. PubMed ID: 18299694
    [Abstract] [Full Text] [Related]

  • 10. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
    Nakayama H.
    Clin Calcium; 2006 Jul 30; 16(7):1201-7. PubMed ID: 16816482
    [Abstract] [Full Text] [Related]

  • 11. [Glucocorticoid induced osteoporosis].
    Lange U, Müller-Ladner U.
    Orthopade; 2007 Apr 30; 36(4):381-8; quiz 389-90. PubMed ID: 17665509
    [Abstract] [Full Text] [Related]

  • 12. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD, Papaioannou A.
    Best Pract Res Clin Rheumatol; 2005 Dec 30; 19(6):1039-64. PubMed ID: 16301196
    [Abstract] [Full Text] [Related]

  • 13. [Asthma--prevention of glucocorticoid-induced osteoporosis with etidronate and calcium].
    Pneumologie; 2005 Feb 30; 59(2):94. PubMed ID: 15724219
    [No Abstract] [Full Text] [Related]

  • 14. [Concurrent treatment of osteoporosis including vitamin K].
    Kobayashi S, Shiraki M, Takaoka K.
    Clin Calcium; 2007 Nov 30; 17(11):1731-7. PubMed ID: 17982194
    [Abstract] [Full Text] [Related]

  • 15. An update on glucocorticoid-induced osteoporosis.
    Woolf AD.
    Curr Opin Rheumatol; 2007 Jul 30; 19(4):370-5. PubMed ID: 17551369
    [Abstract] [Full Text] [Related]

  • 16. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
    Soen S.
    Clin Calcium; 2007 Mar 30; 17(3):399-402. PubMed ID: 17339745
    [Abstract] [Full Text] [Related]

  • 17. [Evidence and utility of etidronate for the treatment of osteoporosis].
    Takada J, Iba K, Yamashita T, Yoshizaki T.
    Clin Calcium; 2008 Oct 30; 18(10):1427-33. PubMed ID: 18830039
    [Abstract] [Full Text] [Related]

  • 18. [Osteoporosis management in general practice. Preventing spontaneous bone fractures].
    MMW Fortschr Med; 2010 Jul 01; 152(25-27):54-5. PubMed ID: 20672666
    [No Abstract] [Full Text] [Related]

  • 19. [Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].
    Vestergaard P, Laursen LC, Schwarz P, Brixen K.
    Ugeskr Laeger; 2005 Feb 21; 167(8):898-900. PubMed ID: 15789844
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.